AURKB and non-small cell lung carcinoma: One of these agents is BI 831266, a potent and selective low-molecular-weight inhibitor of Aurora kinase B. Preclinical studies show that BI 831266 inhibits the proliferation of human non-small cell lung cancer (NSCLC), pancreatic cancer, and prostate cancer cell lines.